Review



ntera 2 nt2 cell line  (DSMZ)


Bioz Verified Symbol DSMZ is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    DSMZ ntera 2 nt2 cell line
    Figure 1. In-silico analysis of GPM6B expression. (a) Across several primates, the expression of GPM6B was at its highest level in the human brain. (b) Our analysis of the RNA-seq datasets retrieved from GEO showed a positive correlation between GPM6B and neural cell differentiation markers, such as GFAP, TUBB3, and MAP2, after differentiation of <t>NT2</t> cells into neural cells (21 days under RA treatment). HUM, human; CHP, chimpanzee; OWM, Old-World monkeys; NWM, New-World monkeys; MLM, mouse lemur.
    Ntera 2 Nt2 Cell Line, supplied by DSMZ, used in various techniques. Bioz Stars score: 92/100, based on 20 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ntera+2+nt2+cell+line/NTERA-2/pm38273037-187-0-10
    Average 92 stars, based on 20 article reviews
    ntera 2 nt2 cell line - by Bioz Stars, 2026-10
    92/100 stars

    Images

    1) Product Images from "CRISPR/Cas9-mediated deletion of a GA-repeat in human GPM6B leads to disruption of neural cell differentiation from NT2 cells."

    Article Title: CRISPR/Cas9-mediated deletion of a GA-repeat in human GPM6B leads to disruption of neural cell differentiation from NT2 cells.

    Journal: Scientific reports

    doi: 10.1038/s41598-024-52675-3

    Figure 1. In-silico analysis of GPM6B expression. (a) Across several primates, the expression of GPM6B was at its highest level in the human brain. (b) Our analysis of the RNA-seq datasets retrieved from GEO showed a positive correlation between GPM6B and neural cell differentiation markers, such as GFAP, TUBB3, and MAP2, after differentiation of NT2 cells into neural cells (21 days under RA treatment). HUM, human; CHP, chimpanzee; OWM, Old-World monkeys; NWM, New-World monkeys; MLM, mouse lemur.
    Figure Legend Snippet: Figure 1. In-silico analysis of GPM6B expression. (a) Across several primates, the expression of GPM6B was at its highest level in the human brain. (b) Our analysis of the RNA-seq datasets retrieved from GEO showed a positive correlation between GPM6B and neural cell differentiation markers, such as GFAP, TUBB3, and MAP2, after differentiation of NT2 cells into neural cells (21 days under RA treatment). HUM, human; CHP, chimpanzee; OWM, Old-World monkeys; NWM, New-World monkeys; MLM, mouse lemur.

    Techniques Used: In Silico, Expressing, RNA Sequencing, Cell Differentiation

    Figure 3. Measuring the expression level of the edited GPM6B gene at the RNA and protein levels in NT2 cells. (a) The expression level of GPM6B was evaluated in the untreated and edited NT2 pool cells, using qRT-PCR. The expression level of GPM6B decreased significantly in the edited pool cells (p < 0.05). (b) The expression of GPM6B was assessed in the isolated single clones, using qRT-PCR. The expression of GPM6B was significantly decreased in the C1 cells, compared to the untreated and the SC3 cells. (c) Western blotting assay confirmed that the expression level of GPM6B was decreased in the C1 cells more efficiently, compared to the untreated and SC3 cells. The original blot images are presented in Supplementary Fig. Xd. (d) the predicted TF binding sites at GA-repeat site and its flanking sequence, is presented based on JASPAR CORE 2022 and ChIP-seq data from ENCODE. The GA-repeat site is highlighted with light blue.
    Figure Legend Snippet: Figure 3. Measuring the expression level of the edited GPM6B gene at the RNA and protein levels in NT2 cells. (a) The expression level of GPM6B was evaluated in the untreated and edited NT2 pool cells, using qRT-PCR. The expression level of GPM6B decreased significantly in the edited pool cells (p < 0.05). (b) The expression of GPM6B was assessed in the isolated single clones, using qRT-PCR. The expression of GPM6B was significantly decreased in the C1 cells, compared to the untreated and the SC3 cells. (c) Western blotting assay confirmed that the expression level of GPM6B was decreased in the C1 cells more efficiently, compared to the untreated and SC3 cells. The original blot images are presented in Supplementary Fig. Xd. (d) the predicted TF binding sites at GA-repeat site and its flanking sequence, is presented based on JASPAR CORE 2022 and ChIP-seq data from ENCODE. The GA-repeat site is highlighted with light blue.

    Techniques Used: Expressing, Quantitative RT-PCR, Isolation, Clone Assay, Western Blot, Binding Assay, Sequencing, ChIP-sequencing

    Figure 5. Disrupted differentiation of NT2 cells to astrocytic and neural cells as a result of GA-repeat deletion and GPM6B downregulation. Deletion of the GA-repeat in the regulatory region of GPM6B decreased the expression of this gene. Consequently, the number of differentiated cells expressing GFAP, TUBB3, and MAP2 decreased significantly in the C1 compared to the SC3 cells.
    Figure Legend Snippet: Figure 5. Disrupted differentiation of NT2 cells to astrocytic and neural cells as a result of GA-repeat deletion and GPM6B downregulation. Deletion of the GA-repeat in the regulatory region of GPM6B decreased the expression of this gene. Consequently, the number of differentiated cells expressing GFAP, TUBB3, and MAP2 decreased significantly in the C1 compared to the SC3 cells.

    Techniques Used: Expressing

    Related Articles

    Cell Culture:

    Article Title: CRISPR/Cas9-mediated deletion of a GA-repeat in human GPM6B leads to disruption of neural cell differentiation from NT2 cells
    Article Snippet: .. NTERA-2 (NT2) cell line (Cat. #ACC-527, RRID:CVCL_0034; was purchased from DSMZ-German Collection of Microorganisms and Cell Cultures GmbH), resembling characteristics of human neuronal progenitor cell, cultured in high glucose DMEM supplemented with 1% penicillin-streptomycin, and 10% FBS under optimal growth condition (at 37 °C, 5% CO 2 , 80% humidity). ..



    Similar Products

    95
    ATCC human tgct embryonal carcinoma ec cell lines nt2 d1
    Human Tgct Embryonal Carcinoma Ec Cell Lines Nt2 D1, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ntera+2+nt2+cell+line/NTERA-2+cl%2ED1%3B+Embryonal+Carcinoma%3B+Human/pm41749828-33-1-15
    Average 95 stars, based on 1 article reviews
    human tgct embryonal carcinoma ec cell lines nt2 d1 - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    96
    ATCC nt2 d1 cell line
    Nt2 D1 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ntera+2+nt2+cell+line/NTERA-2+cl%2ED1/pm41611787-211-1-4
    Average 96 stars, based on 1 article reviews
    nt2 d1 cell line - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    95
    ATCC d1 nt2 d1 cell line
    D1 Nt2 D1 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ntera+2+nt2+cell+line/NTERA-2+cl%2ED1%3B+Embryonal+Carcinoma%3B+Human/pm39413983-50-0-23
    Average 95 stars, based on 1 article reviews
    d1 nt2 d1 cell line - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    96
    ATCC embryonic teratocarcinoma cell line nt2 d1
    Embryonic Teratocarcinoma Cell Line Nt2 D1, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ntera+2+nt2+cell+line/NTERA-2+cl%2ED1/pmc11431966-254-2-8
    Average 96 stars, based on 1 article reviews
    embryonic teratocarcinoma cell line nt2 d1 - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    92
    DSMZ ntera 2 nt2 cell line
    Figure 1. In-silico analysis of GPM6B expression. (a) Across several primates, the expression of GPM6B was at its highest level in the human brain. (b) Our analysis of the RNA-seq datasets retrieved from GEO showed a positive correlation between GPM6B and neural cell differentiation markers, such as GFAP, TUBB3, and MAP2, after differentiation of <t>NT2</t> cells into neural cells (21 days under RA treatment). HUM, human; CHP, chimpanzee; OWM, Old-World monkeys; NWM, New-World monkeys; MLM, mouse lemur.
    Ntera 2 Nt2 Cell Line, supplied by DSMZ, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ntera+2+nt2+cell+line/NTERA-2/pm38273037-187-0-10
    Average 92 stars, based on 1 article reviews
    ntera 2 nt2 cell line - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    92
    DSMZ differentiation ntera 2 nt2 cell line
    Figure 1. In-silico analysis of GPM6B expression. (a) Across several primates, the expression of GPM6B was at its highest level in the human brain. (b) Our analysis of the RNA-seq datasets retrieved from GEO showed a positive correlation between GPM6B and neural cell differentiation markers, such as GFAP, TUBB3, and MAP2, after differentiation of <t>NT2</t> cells into neural cells (21 days under RA treatment). HUM, human; CHP, chimpanzee; OWM, Old-World monkeys; NWM, New-World monkeys; MLM, mouse lemur.
    Differentiation Ntera 2 Nt2 Cell Line, supplied by DSMZ, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ntera+2+nt2+cell+line/NTERA-2/ppr0767820-142-3-14
    Average 92 stars, based on 1 article reviews
    differentiation ntera 2 nt2 cell line - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    Image Search Results


    Figure 1. In-silico analysis of GPM6B expression. (a) Across several primates, the expression of GPM6B was at its highest level in the human brain. (b) Our analysis of the RNA-seq datasets retrieved from GEO showed a positive correlation between GPM6B and neural cell differentiation markers, such as GFAP, TUBB3, and MAP2, after differentiation of NT2 cells into neural cells (21 days under RA treatment). HUM, human; CHP, chimpanzee; OWM, Old-World monkeys; NWM, New-World monkeys; MLM, mouse lemur.

    Journal: Scientific reports

    Article Title: CRISPR/Cas9-mediated deletion of a GA-repeat in human GPM6B leads to disruption of neural cell differentiation from NT2 cells.

    doi: 10.1038/s41598-024-52675-3

    Figure Lengend Snippet: Figure 1. In-silico analysis of GPM6B expression. (a) Across several primates, the expression of GPM6B was at its highest level in the human brain. (b) Our analysis of the RNA-seq datasets retrieved from GEO showed a positive correlation between GPM6B and neural cell differentiation markers, such as GFAP, TUBB3, and MAP2, after differentiation of NT2 cells into neural cells (21 days under RA treatment). HUM, human; CHP, chimpanzee; OWM, Old-World monkeys; NWM, New-World monkeys; MLM, mouse lemur.

    Article Snippet: NTERA-2 (NT2) cell line (Cat. #ACC-527, RRID:CVCL_0034; was purchased from DSMZ-German Collection of Microorganisms and Cell Cultures GmbH), resembling characteristics of human neuronal progenitor cell, Figure 4.

    Techniques: In Silico, Expressing, RNA Sequencing, Cell Differentiation

    Figure 3. Measuring the expression level of the edited GPM6B gene at the RNA and protein levels in NT2 cells. (a) The expression level of GPM6B was evaluated in the untreated and edited NT2 pool cells, using qRT-PCR. The expression level of GPM6B decreased significantly in the edited pool cells (p < 0.05). (b) The expression of GPM6B was assessed in the isolated single clones, using qRT-PCR. The expression of GPM6B was significantly decreased in the C1 cells, compared to the untreated and the SC3 cells. (c) Western blotting assay confirmed that the expression level of GPM6B was decreased in the C1 cells more efficiently, compared to the untreated and SC3 cells. The original blot images are presented in Supplementary Fig. Xd. (d) the predicted TF binding sites at GA-repeat site and its flanking sequence, is presented based on JASPAR CORE 2022 and ChIP-seq data from ENCODE. The GA-repeat site is highlighted with light blue.

    Journal: Scientific reports

    Article Title: CRISPR/Cas9-mediated deletion of a GA-repeat in human GPM6B leads to disruption of neural cell differentiation from NT2 cells.

    doi: 10.1038/s41598-024-52675-3

    Figure Lengend Snippet: Figure 3. Measuring the expression level of the edited GPM6B gene at the RNA and protein levels in NT2 cells. (a) The expression level of GPM6B was evaluated in the untreated and edited NT2 pool cells, using qRT-PCR. The expression level of GPM6B decreased significantly in the edited pool cells (p < 0.05). (b) The expression of GPM6B was assessed in the isolated single clones, using qRT-PCR. The expression of GPM6B was significantly decreased in the C1 cells, compared to the untreated and the SC3 cells. (c) Western blotting assay confirmed that the expression level of GPM6B was decreased in the C1 cells more efficiently, compared to the untreated and SC3 cells. The original blot images are presented in Supplementary Fig. Xd. (d) the predicted TF binding sites at GA-repeat site and its flanking sequence, is presented based on JASPAR CORE 2022 and ChIP-seq data from ENCODE. The GA-repeat site is highlighted with light blue.

    Article Snippet: NTERA-2 (NT2) cell line (Cat. #ACC-527, RRID:CVCL_0034; was purchased from DSMZ-German Collection of Microorganisms and Cell Cultures GmbH), resembling characteristics of human neuronal progenitor cell, Figure 4.

    Techniques: Expressing, Quantitative RT-PCR, Isolation, Clone Assay, Western Blot, Binding Assay, Sequencing, ChIP-sequencing

    Figure 5. Disrupted differentiation of NT2 cells to astrocytic and neural cells as a result of GA-repeat deletion and GPM6B downregulation. Deletion of the GA-repeat in the regulatory region of GPM6B decreased the expression of this gene. Consequently, the number of differentiated cells expressing GFAP, TUBB3, and MAP2 decreased significantly in the C1 compared to the SC3 cells.

    Journal: Scientific reports

    Article Title: CRISPR/Cas9-mediated deletion of a GA-repeat in human GPM6B leads to disruption of neural cell differentiation from NT2 cells.

    doi: 10.1038/s41598-024-52675-3

    Figure Lengend Snippet: Figure 5. Disrupted differentiation of NT2 cells to astrocytic and neural cells as a result of GA-repeat deletion and GPM6B downregulation. Deletion of the GA-repeat in the regulatory region of GPM6B decreased the expression of this gene. Consequently, the number of differentiated cells expressing GFAP, TUBB3, and MAP2 decreased significantly in the C1 compared to the SC3 cells.

    Article Snippet: NTERA-2 (NT2) cell line (Cat. #ACC-527, RRID:CVCL_0034; was purchased from DSMZ-German Collection of Microorganisms and Cell Cultures GmbH), resembling characteristics of human neuronal progenitor cell, Figure 4.

    Techniques: Expressing